uniQure (Commercial Gene Therapy Manufacturing Operations) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
uniQure (Commercial Gene Therapy Manufacturing Operations) General Information
Description
Manufacturer of gene therapy products based in Lexington, Massachusetts. The company specializes in offering commercial-scale products such as transformative therapies for patients with severe medical needs.
Contact Information
Corporate Office
- Lexington, KY
- United States
Corporate Office
- Lexington, KY
- United States
uniQure (Commercial Gene Therapy Manufacturing Operations) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
uniQure (Commercial Gene Therapy Manufacturing Operations) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
uniQure (Commercial Gene Therapy Manufacturing Operations) FAQs
-
Where is uniQure (Commercial Gene Therapy Manufacturing Operations) headquartered?
uniQure (Commercial Gene Therapy Manufacturing Operations) is headquartered in Lexington, KY.
-
What industry is uniQure (Commercial Gene Therapy Manufacturing Operations) in?
uniQure (Commercial Gene Therapy Manufacturing Operations)’s primary industry is Other Devices and Supplies.
-
Is uniQure (Commercial Gene Therapy Manufacturing Operations) a private or public company?
uniQure (Commercial Gene Therapy Manufacturing Operations) is a Private company.
-
What is the current valuation of uniQure (Commercial Gene Therapy Manufacturing Operations)?
The current valuation of uniQure (Commercial Gene Therapy Manufacturing Operations) is .
-
What is uniQure (Commercial Gene Therapy Manufacturing Operations)’s current revenue?
The current revenue for uniQure (Commercial Gene Therapy Manufacturing Operations) is .
-
Who are uniQure (Commercial Gene Therapy Manufacturing Operations)’s investors?
uniQure has invested in uniQure (Commercial Gene Therapy Manufacturing Operations).
-
When was uniQure (Commercial Gene Therapy Manufacturing Operations) acquired?
uniQure (Commercial Gene Therapy Manufacturing Operations) was acquired on 23-Jul-2024.
-
Who acquired uniQure (Commercial Gene Therapy Manufacturing Operations)?
uniQure (Commercial Gene Therapy Manufacturing Operations) was acquired by Genezen Laboratories.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process